← FDA DRUG APPROVALS

FDA ANDA · ANDA060427

NEO-POLYCIN

Sponsor: DOW PHARM

APPLICATION
ANDA060427
TYPE
ANDA
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

NEO-POLYCINDiscontinued
GRAMICIDIN 0.025MG/ML, NEOMYCIN SULFATE EQ 1.75MG BASE/ML, POLYMYXIN B SULFATE 10,000 UNITS/ML · SOLUTION/DROPS · OPHTHALMIC
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →